Erika Vacchelli

Affiliations: 
University Paris 11 
Area:
Breast cancer, Signature, Non small cell lung cancer, Head and neck carcinoma, Immunogenic cell death, ECE1, PZP, Rs2241880, Rs3751143, Rs4986790, Cancer
Google:
"Erika Vacchelli"

Parents

Sign in to add mentor
Guido Kroemer grad student 2014 University Paris 11
 (Immunogenetic determinants of chemotherapy response in cancer)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lévesque S, Le Naour J, Pietrocola F, et al. (2019) A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice. Oncoimmunology. 8: e1657375
Liu P, Zhao L, Pol J, et al. (2019) Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1883
Liu P, Zhao L, Pol J, et al. (2019) Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1486
Castoldi F, Vacchelli E, Zitvogel L, et al. (2019) Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. Oncoimmunology. 8: e1498285
Enot DP, Vacchelli E, Jacquelot N, et al. (2018) TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves. Oncoimmunology. 7: e1462431
Biselli E, Agliari E, Barra A, et al. (2017) Organs on chip approach: a tool to evaluate cancer -immune cells interactions. Scientific Reports. 7: 12737
Semeraro M, Adam J, Stoll G, et al. (2016) The ratio of CD8(+)/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 5: e1218106
Vacchelli E, Bloy N, Aranda F, et al. (2016) Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 5: e1214790
Pietrocola F, Pol J, Vacchelli E, et al. (2016) Autophagy induction for the treatment of cancer. Autophagy. 12: 1962-1964
Yang H, Ma Y, Chen G, et al. (2016) Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology. 5: e1149673
See more...